Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rankning i aktier #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aktiekurs
$0.0202
Senast synkroniserad: 2024-11-19
Marknadsvärde
$44.67K
Förändring (1 dag)
-0.49%
Förändring (1 år)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Kategori

Vinst för Notable Labs, Ltd. (NTBL)
Vinst i Jun 2024 TTM: $-8.99M
Enligt de senaste finansiella rapporterna från Notable Labs, Ltd. är företagets nuvarande vinst $-8.99M. År 2022 hade företaget en vinst på $-14.41M, en ökning jämfört med vinsten år 2021 som var $-16.05M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Notable Labs, Ltd. från 2015 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$5.27B -58,807.85%
US
$1.95B -21,810.07%
NL
- -
CH
- -
KR
$3.01B -33,552.61%
BE